Portfolio (Quarterly)
Guide ↗
VR ADVISER, LLC
· CIK 0001615982| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | APOGEE THERAPEUTICS INC | — | 8,493,321.0 | $337.4M | 18.99% | NEW | — | $39.73 | — |
| 2 | — | METSERA INC | — | 3,750,662.0 | $196.3M | 11.05% | NEW | — | $52.33 | — |
| 3 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 13,161,462.0 | $153.9M | 8.66% | NEW | — | $11.69 | -18.7% |
| 4 | — | CIDARA THERAPEUTICS INC | — | 946,788.0 | $90.7M | 5.10% | NEW | — | $95.76 | — |
| 5 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 3,882,709.0 | $83.8M | 4.72% | NEW | — | $21.58 | -21.0% |
| 6 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 6,728,985.0 | $82.0M | 4.61% | NEW | — | $12.18 | +119.7% |
| 7 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 4,148,428.0 | $79.8M | 4.49% | NEW | — | $19.23 | +232.3% |
| 8 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 6,596,885.0 | $79.2M | 4.46% | NEW | — | $12.00 | -30.5% |
| 9 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 3,226,331.0 | $66.0M | 3.72% | NEW | — | $20.47 | +110.5% |
| 10 | COGT | COGENT BIOSCIENCES INC | Healthcare | 4,000,000.0 | $57.4M | 3.23% | NEW | — | $14.36 | +138.1% |
| 11 | CTMX | CYTOMX THERAPEUTICS INC | Healthcare | 15,561,500.0 | $49.6M | 2.79% | NEW | — | $3.19 | +18.5% |
| 12 | ABVX | ABIVAX SA | Healthcare | 576,729.0 | $49.0M | 2.76% | NEW | — | $84.90 | +34.9% |
| 13 | SVRA | SAVARA INC | Healthcare | 12,681,043.0 | $45.3M | 2.55% | NEW | — | $3.57 | +47.6% |
| 14 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 2,685,448.0 | $45.0M | 2.53% | NEW | — | $16.76 | +351.4% |
| 15 | ERAS | ERASCA INC | Healthcare | 17,857,083.0 | $38.9M | 2.19% | NEW | — | $2.18 | +375.7% |
| 16 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 960,803.0 | $37.8M | 2.13% | NEW | — | $39.35 | +116.9% |
| 17 | — | ENGENE HOLDINGS INC | — | 5,046,414.0 | $34.5M | 1.94% | NEW | — | $6.83 | — |
| 18 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 1,230,769.0 | $31.9M | 1.80% | NEW | — | $25.93 | +1.9% |
| 19 | JBIO | JADE BIOSCIENCES INC | Healthcare | 3,220,364.0 | $27.8M | 1.56% | NEW | — | $8.63 | +179.6% |
| 20 | DYN | DYNE THERAPEUTICS INC | Healthcare | 2,173,913.0 | $27.5M | 1.55% | NEW | — | $12.65 | +44.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%